Capsaicin topical - Maruishi Pharmaceutical

Drug Profile

Capsaicin topical - Maruishi Pharmaceutical

Alternative Names: MR3H3

Latest Information Update: 09 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Maruishi
  • Developer Maruishi Pharmaceutical
  • Class Antipruritics; Catechols; Local anaesthetics; Monounsaturated fatty acids; Non-opioid analgesics; Polyunsaturated alkamides; Small molecules
  • Mechanism of Action Nociceptin receptor antagonists; TRPV1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Postherpetic neuralgia

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 27 May 2005 Three preclinical studies have been added to the Pain pharmacodynamics section ,)
  • 12 May 2005 Phase-II clinical trials in Postherpetic neuralgia in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top